glp-1 for weight loss canada in Canada: What It Is, How It Works, and What Canadians Should Know – iFinance Understanding Weight Loss Medications |

Additionally, the review seeks to highlight emerging strategies for personalized microbiome-based treatments and their potential to improve the management of GI disorders

Specifically, they are approved in patients who have a BMI 30 kg/m 2 or who have a BMI 27 kg/m 2 and an obesity-related health condition (eg, diabetes, hypertension, or dyslipidemia)

While their effects on gastrointestinal motility are well recognised, the potential link between GLP-1 RAs and peptic ulcer disease (PUD) has not been thoroughly investigated

Regulatory bodies worldwide are continuously monitoring and updating guidance to keep patients safe

Read more: The GLP-1 RevolutionEveryone (And Their Moms) Are On GLP-1s